Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

Modeling perimenopause in Sprague-Dawley rats by chemical manipulation of the transition to ovarian failure.

Frye JB, Lukefahr AL, Wright LE, Marion SL, Hoyer PB, Funk JL.

Comp Med. 2012 Jun;62(3):193-202.

2.

Follicle-stimulating hormone increases bone mass in female mice.

Allan CM, Kalak R, Dunstan CR, McTavish KJ, Zhou H, Handelsman DJ, Seibel MJ.

Proc Natl Acad Sci U S A. 2010 Dec 28;107(52):22629-34. doi: 10.1073/pnas.1012141108. Epub 2010 Dec 13.

3.

Bone loss in ovariectomized rats: dominant role for estrogen but apparently not for FSH.

Rouach V, Katzburg S, Koch Y, Stern N, Somjen D.

J Cell Biochem. 2011 Jan;112(1):128-37. doi: 10.1002/jcb.22908.

PMID:
21053364
4.

What is the missing hormonal factor controlling menopausal bone resorption?

Ebeling PR.

J Clin Endocrinol Metab. 2010 Nov;95(11):4864-6. doi: 10.1210/jc.2010-1506. No abstract available.

PMID:
21051582
5.

Effects of suppression of follicle-stimulating hormone secretion on bone resorption markers in postmenopausal women.

Drake MT, McCready LK, Hoey KA, Atkinson EJ, Khosla S.

J Clin Endocrinol Metab. 2010 Nov;95(11):5063-8. doi: 10.1210/jc.2010-1103. Epub 2010 Jul 7.

6.

Commentary-FSH and bone 2010: evolving evidence.

Iqbal J, Sun L, Zaidi M.

Eur J Endocrinol. 2010 Jul;163(1):173-6. doi: 10.1530/EJE-10-0397. Epub 2010 May 6.

7.

Bone turnover across the menopause transition : The role of gonadal inhibins.

Nicks KM, Fowler TW, Akel NS, Perrien DS, Suva LJ, Gaddy D.

Ann N Y Acad Sci. 2010 Mar;1192:153-60. doi: 10.1111/j.1749-6632.2009.05349.x. Review.

8.

Amount of bone loss in relation to time around the final menstrual period and follicle-stimulating hormone staging of the transmenopause.

Sowers MR, Zheng H, Jannausch ML, McConnell D, Nan B, Harlow S, Randolph JF Jr.

J Clin Endocrinol Metab. 2010 May;95(5):2155-62. doi: 10.1210/jc.2009-0659. Epub 2010 Mar 9.

9.

Further evidence for direct pro-resorptive actions of FSH.

Sun L, Zhang Z, Zhu LL, Peng Y, Liu X, Li J, Agrawal M, Robinson LJ, Iqbal J, Blair HC, Zaidi M.

Biochem Biophys Res Commun. 2010 Mar 26;394(1):6-11. doi: 10.1016/j.bbrc.2010.02.113. Epub 2010 Feb 19.

10.

Inhibins: from reproductive hormones to tumor suppressors.

Stenvers KL, Findlay JK.

Trends Endocrinol Metab. 2010 Mar;21(3):174-80. doi: 10.1016/j.tem.2009.11.009. Epub 2009 Dec 11. Review.

PMID:
20005735
11.

Regulation of osteoblastogenesis and osteoclastogenesis by the other reproductive hormones, Activin and Inhibin.

Nicks KM, Perrien DS, Akel NS, Suva LJ, Gaddy D.

Mol Cell Endocrinol. 2009 Oct 30;310(1-2):11-20. doi: 10.1016/j.mce.2009.07.001. Epub 2009 Jul 15. Review.

12.

Interrelationships between ovarian and pituitary hormones in ovulatory menstrual cycles across reproductive age.

Robertson DM, Hale GE, Jolley D, Fraser IS, Hughes CL, Burger HG.

J Clin Endocrinol Metab. 2009 Jan;94(1):138-44. doi: 10.1210/jc.2008-1684. Epub 2008 Oct 14.

PMID:
18854393
13.

Follicle stimulating hormone and its rate of change in defining menopause transition stages.

Sowers MR, Zheng H, McConnell D, Nan B, Harlow S, Randolph JF Jr.

J Clin Endocrinol Metab. 2008 Oct;93(10):3958-64. doi: 10.1210/jc.2008-0482. Epub 2008 Jul 22.

14.

Cycle and hormone changes during perimenopause: the key role of ovarian function.

Burger HG, Hale GE, Dennerstein L, Robertson DM.

Menopause. 2008 Jul-Aug;15(4 Pt 1):603-12. doi: 10.1097/gme.0b013e318174ea4d.

PMID:
18574431
15.

Follicle-stimulating hormone does not impact male bone mass in vivo or human male osteoclasts in vitro.

Ritter V, Thuering B, Saint Mezard P, Luong-Nguyen NH, Seltenmeyer Y, Junker U, Fournier B, Susa M, Morvan F.

Calcif Tissue Int. 2008 May;82(5):383-91. doi: 10.1007/s00223-008-9134-5. Epub 2008 May 9.

PMID:
18465073
16.

Comparison of skeletal effects of ovariectomy versus chemically induced ovarian failure in mice.

Wright LE, Christian PJ, Rivera Z, Van Alstine WG, Funk JL, Bouxsein ML, Hoyer PB.

J Bone Miner Res. 2008 Aug;23(8):1296-303. doi: 10.1359/jbmr.080309.

17.

Bone mineral density changes during the menopause transition in a multiethnic cohort of women.

Finkelstein JS, Brockwell SE, Mehta V, Greendale GA, Sowers MR, Ettinger B, Lo JC, Johnston JM, Cauley JA, Danielson ME, Neer RM.

J Clin Endocrinol Metab. 2008 Mar;93(3):861-8. Epub 2007 Dec 26.

18.
19.

Differential effects of aging on activin A and its binding protein, follistatin, across the menopause transition.

Reame NE, Lukacs JL, Olton P, Ansbacher R, Padmanabhan V.

Fertil Steril. 2007 Oct;88(4):1003-5. Epub 2007 Apr 16.

20.

The rodent estrous cycle: characterization of vaginal cytology and its utility in toxicological studies.

Goldman JM, Murr AS, Cooper RL.

Birth Defects Res B Dev Reprod Toxicol. 2007 Apr;80(2):84-97. Review.

PMID:
17342777

Supplemental Content

Support Center